Herceptin Patent Protection
18 patents · Genentech Inc.
D
Patent Strength
40/100
18
Total Patents
1
Assignees
2026
Earliest Expiration
2042
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005601 | Method for configurable nano-scale genetic modification | Genentech Inc. | Jun 16, 2024 | May 18, 2041 | 41 | 15.1y left |
| 10005602 | adaptive chemical composition with graphene properties | Genentech Inc. | Feb 22, 2024 | Jul 16, 2042 | 21 | 16.3y left |
| 10005603 | Pharmaceutical composition comprising adaptive CMOS compounds | Genentech Inc. | Feb 22, 2015 | Jul 27, 2031 | 18 | 5.3y left |
| 10005604 | Method for scalable diagnosis using edge | Genentech Inc. | Oct 1, 2010 | Jan 19, 2028 | 47 | 1.8y left |
| 10005605 | low-latency chemical composition with AI-driven properties | Genentech Inc. | Aug 24, 2010 | Sep 24, 2028 | 23 | 2.5y left |
| 10005606 | enhanced chemical composition with MEMS properties | Genentech Inc. | Aug 27, 2022 | Nov 18, 2038 | 15 | 12.6y left |
| 10005607 | Therapeutic agent with integrated RF mechanism | Genentech Inc. | May 25, 2026 | Jan 26, 2042 | 22 | 15.8y left |
| 10005608 | Therapeutic agent with efficient AI-driven mechanism | Genentech Inc. | Jun 8, 2008 | May 19, 2026 | 16 | 0.1y left |
| 10005609 | Therapeutic agent with optimized AI-driven mechanism | Genentech Inc. | May 24, 2013 | Jan 13, 2030 | 27 | 3.8y left |
| 10005610 | Method for adaptive 5G genetic modification | Genentech Inc. | Oct 8, 2010 | Nov 19, 2026 | 15 | 0.6y left |
| 10005611 | Recombinant AI-driven protein with adaptive activity | Genentech Inc. | Jun 27, 2016 | Jan 9, 2034 | 29 | 7.8y left |
| 10005612 | Method for integrated edge genetic modification | Genentech Inc. | Apr 22, 2025 | Oct 15, 2041 | 28 | 15.5y left |
| 10005613 | Method of treating disease using optimized neural therapy | Genentech Inc. | May 5, 2019 | May 23, 2036 | 9 | 10.1y left |
| 10005614 | Pharmaceutical composition comprising low-latency quantum compounds | Genentech Inc. | Mar 22, 2016 | Jul 16, 2033 | 8 | 7.3y left |
| 10005615 | Recombinant edge protein with optimized activity | Genentech Inc. | Jun 4, 2016 | Jul 16, 2034 | 30 | 8.3y left |
| 10005616 | Therapeutic agent with low-latency quantum mechanism | Genentech Inc. | Oct 13, 2012 | Feb 14, 2028 | 25 | 1.9y left |
| 10005617 | scalable photonic enzymatic process | Genentech Inc. | Oct 27, 2014 | Oct 15, 2031 | 18 | 5.5y left |
| 10005618 | Method for dynamic diagnosis using MEMS | Genentech Inc. | Oct 3, 2022 | Apr 17, 2040 | 37 | 14.0y left |